Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C.

[1]  T. Chittenden,et al.  Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen. , 2006, Cancer research.

[2]  J. Lambert.  Drug-conjugated monoclonal antibodies for the treatment of cancer. , 2005, Current opinion in pharmacology.

[3]  G. Speake,et al.  Recent developments related to the EGFR as a target for cancer chemotherapy. , 2005, Current opinion in pharmacology.

[4]  P. Polakis.  Arming antibodies for cancer therapy. , 2005, Current opinion in pharmacology.

[5]  X. Wu,et al.  Tumor specific novel taxoid-monoclonal antibody conjugates. , 2002, Current medicinal chemistry.

[6]  E. J. V. van Zoelen,et al.  Ligand-induced Lysosomal Epidermal Growth Factor Receptor (EGFR) Degradation Is Preceded by Proteasome-dependent EGFR De-ubiquitination* , 2003, Journal of Biological Chemistry.

[7]  Carlos L Arteaga,et al.  ErbB-targeted therapeutic approaches in human cancer. , 2003, Experimental cell research.

[8]  A. Wahl,et al.  Protease-mediated fragmentation of p-amidobenzyl ethers: a new strategy for the activation of anticancer prodrugs. , 2002, The Journal of organic chemistry.

[9]  I. Bernstein,et al.  An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. , 2002, Bioconjugate chemistry.

[10]  G. Tortora,et al.  A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  R. Nicholson,et al.  EGFR and cancer prognosis. , 2001, European journal of cancer.

[12]  A. Scott,et al.  Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. , 2001, Cancer research.

[13]  X. H. Chen,et al.  Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  G. Gaedicke,et al.  Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1. , 2000, Cancer research.

[15]  J. Mendelsohn.  Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  L. Norton,et al.  Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Sorkin,et al.  Endocytosis of Functional Epidermal Growth Factor Receptor-Green Fluorescent Protein Chimera* , 1998, The Journal of Biological Chemistry.

[18]  M. Tomasz,et al.  Mitomycin C: small, fast and deadly (but very selective). , 1995, Chemistry & biology.

[19]  L. Wang,et al.  Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Wang,et al.  Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. , 1989, The Journal of biological chemistry.

[21]  M. Sela,et al.  Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Mendelsohn,et al.  Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. , 1983, Molecular biology & medicine.

[23]  J. Mendelsohn,et al.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Singer,et al.  Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. , 1978, Proceedings of the National Academy of Sciences of the United States of America.